| |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Inibitori di pompa protonica e polmonite
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Nuove linee guida GOLD sulla BPCO - Seconda parte
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Acne: linee guida a confronto
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Nuove linee guida GOLD sulla BPCO (parte prima)
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Pericarditi ricorrenti: utile l' Anakinra
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Gliptine, glitazoni ed esiti cardiovascolari
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Il Disease Mongering, ovvero il potere dell'Illusione (parte 2)
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Curare i sani: il successo del Disease Mongering (parte 1)
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Ossigenoterapia nella BPCO moderata: e' utile?
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
Pagina precedente Pagina successiva
| |
|